Patrick P. Grace Sells 500 Shares of Chemed Corp. (CHE) Stock
Chemed Corp. (NYSE:CHE) Director Patrick P. Grace sold 500 shares of the firm’s stock in a transaction dated Monday, October 2nd. The shares were sold at an average price of $201.48, for a total value of $100,740.00. Following the transaction, the director now owns 4,515 shares of the company’s stock, valued at $909,682.20. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.
Shares of Chemed Corp. (NYSE:CHE) traded up 0.72% during mid-day trading on Monday, hitting $203.50. The stock had a trading volume of 76,903 shares. Chemed Corp. has a 12-month low of $132.92 and a 12-month high of $216.01. The company’s 50 day moving average price is $193.25 and its 200 day moving average price is $196.09. The stock has a market cap of $3.25 billion, a P/E ratio of 50.48 and a beta of 1.13.
Chemed Corp. (NYSE:CHE) last released its quarterly earnings data on Tuesday, July 25th. The company reported $2.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.89 by $0.26. Chemed Corp. had a net margin of 4.16% and a return on equity of 26.18%. The company had revenue of $415.06 million during the quarter, compared to analyst estimates of $407.56 million. During the same quarter in the prior year, the business earned $1.80 earnings per share. The business’s quarterly revenue was up 6.3% compared to the same quarter last year. Equities research analysts predict that Chemed Corp. will post $8.21 EPS for the current fiscal year.
A number of institutional investors have recently made changes to their positions in CHE. USA Financial Portformulas Corp acquired a new stake in Chemed Corp. in the 2nd quarter valued at $292,000. Dynamic Technology Lab Private Ltd purchased a new position in Chemed Corp. in the second quarter valued at about $648,000. Piedmont Investment Advisors LLC purchased a new position in Chemed Corp. in the second quarter valued at about $711,000. Kalos Management Inc. raised its position in Chemed Corp. by 0.7% in the second quarter. Kalos Management Inc. now owns 6,521 shares of the company’s stock valued at $1,333,000 after purchasing an additional 45 shares during the period. Finally, Coldstream Capital Management Inc. purchased a new position in Chemed Corp. in the second quarter valued at about $229,000. 96.96% of the stock is owned by hedge funds and other institutional investors.
A number of analysts have issued reports on CHE shares. Zacks Investment Research lowered shares of Chemed Corp. from a “buy” rating to a “hold” rating in a research note on Tuesday, September 26th. Royal Bank Of Canada reissued a “hold” rating and issued a $209.00 price objective on shares of Chemed Corp. in a research note on Monday, July 31st. BidaskClub lowered shares of Chemed Corp. from a “buy” rating to a “hold” rating in a research note on Wednesday, August 2nd. KeyCorp initiated coverage on shares of Chemed Corp. in a report on Monday, August 28th. They issued a “sector weight” rating for the company. Finally, TheStreet cut shares of Chemed Corp. from a “b+” rating to a “c+” rating in a report on Tuesday, July 25th. Three investment analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $215.00.
About Chemed Corp.
Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.
Receive News & Stock Ratings for Chemed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corp. and related stocks with our FREE daily email newsletter.